<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>CytoCares | wechat-feeds</title><link>http://MzAxNjQ3NjI4MA.favicon.privacyhide.com/favicon.ico</link><description>为您传递细胞治疗相关行业信息与技术进展，共同促进国内免疫治疗技术发展与行业繁荣。</description><managingEditor> (hellodword)</managingEditor><pubDate>Mon, 08 Mar 2021 20:30:54 +0800</pubDate><image><url>http://MzAxNjQ3NjI4MA.favicon.privacyhide.com/favicon.ico</url><title>CytoCares | wechat-feeds</title><link>http://MzAxNjQ3NjI4MA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>全能核酸酶，为生物制品规模化生产解决核酸残留困扰</title><link>https://mp.weixin.qq.com/s/0-YdJcwwvVOmg33oBbi7Jw</link><description></description><content:encoded><![CDATA[全能核酸酶，为生物制品规模化生产解决核酸残留困扰]]></content:encoded><pubDate>Mon, 08 Mar 2021 19:13:18 +0800</pubDate></item><item><title>抗体药物动态-20210308</title><link>https://mp.weixin.qq.com/s/Jnbste15LeXV5D50RUV9Kg</link><description></description><content:encoded><![CDATA[抗体药物动态-20210308]]></content:encoded><pubDate>Mon, 08 Mar 2021 19:13:18 +0800</pubDate></item><item><title>Moderna公布IL-12 mRNA肿瘤疫苗I期数据，联用Durvalumab效果可期</title><link>https://mp.weixin.qq.com/s/otdAYcav2O7EuQpMoVbV0g</link><description></description><content:encoded><![CDATA[Moderna公布IL-12 mRNA肿瘤疫苗I期数据，联用Durvalumab效果可期]]></content:encoded><pubDate>Fri, 05 Mar 2021 18:42:06 +0800</pubDate></item><item><title>类风湿性关节炎疾病进程的三个检查点</title><link>https://mp.weixin.qq.com/s/PeomC7n97tNOUyLepUOa3w</link><description></description><content:encoded><![CDATA[类风湿性关节炎疾病进程的三个检查点]]></content:encoded><pubDate>Thu, 04 Mar 2021 18:32:48 +0800</pubDate></item><item><title>抗体药物动态-20210304</title><link>https://mp.weixin.qq.com/s/yWc1h8ohYluQdtj6q1nkSg</link><description></description><content:encoded><![CDATA[抗体药物动态-20210304]]></content:encoded><pubDate>Thu, 04 Mar 2021 18:32:48 +0800</pubDate></item><item><title>CAR-T细胞治疗为什么用自己的细胞更好？《Nature》子刊最新研究给出答案</title><link>https://mp.weixin.qq.com/s/Ot2A3FcVBTjzK66KId3_ew</link><description></description><content:encoded><![CDATA[CAR-T细胞治疗为什么用自己的细胞更好？《Nature》子刊最新研究给出答案]]></content:encoded><pubDate>Wed, 03 Mar 2021 19:14:59 +0800</pubDate></item><item><title>“睡美人” CAR-T</title><link>https://mp.weixin.qq.com/s/29wpdfu_VxIo8wMls-j1-Q</link><description></description><content:encoded><![CDATA[“睡美人” CAR-T]]></content:encoded><pubDate>Tue, 02 Mar 2021 18:52:12 +0800</pubDate></item><item><title>简述非典型T细胞（NKT、MAIT、γδT）</title><link>https://mp.weixin.qq.com/s/VmKCt7BdZb566rs7y_FQhw</link><description></description><content:encoded><![CDATA[简述非典型T细胞（NKT、MAIT、γδT）]]></content:encoded><pubDate>Mon, 01 Mar 2021 17:59:20 +0800</pubDate></item><item><title>抗体药物动态-20210301</title><link>https://mp.weixin.qq.com/s/vSwTZFIEn7l5jovvzxq70A</link><description></description><content:encoded><![CDATA[抗体药物动态-20210301]]></content:encoded><pubDate>Mon, 01 Mar 2021 17:59:20 +0800</pubDate></item><item><title>4-1BB+T细胞：免疫治疗革命的主角</title><link>https://mp.weixin.qq.com/s/2zhfiibaYSQ0SnGOEGb0FA</link><description></description><content:encoded><![CDATA[4-1BB+T细胞：免疫治疗革命的主角]]></content:encoded><pubDate>Fri, 26 Feb 2021 19:20:26 +0800</pubDate></item><item><title>CAR-T里程碑专利，及全球概况</title><link>https://mp.weixin.qq.com/s/K5yOyb4wyc3jFxjC_irXxw</link><description></description><content:encoded><![CDATA[CAR-T里程碑专利，及全球概况]]></content:encoded><pubDate>Thu, 25 Feb 2021 18:51:39 +0800</pubDate></item><item><title>抗体药物动态-20210225</title><link>https://mp.weixin.qq.com/s/G4hQyeHmPlZaFIEaDRCr3g</link><description></description><content:encoded><![CDATA[抗体药物动态-20210225]]></content:encoded><pubDate>Thu, 25 Feb 2021 18:51:39 +0800</pubDate></item><item><title>双特异性纳米抗体，激活1型NKT细胞</title><link>https://mp.weixin.qq.com/s/J2Zf840PrOFQcNEeRI4xxQ</link><description></description><content:encoded><![CDATA[双特异性纳米抗体，激活1型NKT细胞]]></content:encoded><pubDate>Wed, 24 Feb 2021 18:16:27 +0800</pubDate></item><item><title>抗体药物动态-20210224</title><link>https://mp.weixin.qq.com/s/pXrDPFrBRzkkzBPLldMXiQ</link><description></description><content:encoded><![CDATA[抗体药物动态-20210224]]></content:encoded><pubDate>Wed, 24 Feb 2021 18:16:27 +0800</pubDate></item><item><title>自身免疫与炎症性疾病生物疗法三十年来的经验总结</title><link>https://mp.weixin.qq.com/s/d6sJwLUn7ir1Wo37LYvLTg</link><description></description><content:encoded><![CDATA[自身免疫与炎症性疾病生物疗法三十年来的经验总结]]></content:encoded><pubDate>Tue, 23 Feb 2021 18:44:45 +0800</pubDate></item></channel></rss>